Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-04-25

FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc, resulting in an approved modification to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)